Erika Smith

Columnist, LA Times

Columnist at the LA Times

Erika Smith on KCRW

Some people view Johnson & Johnson as a “second class shot" due to its comparatively lower efficacy rating, reports LA Times columnist Erika Smith.

Why the Johnson and Johnson vaccine shouldn’t be viewed as second class

Some people view Johnson & Johnson as a “second class shot" due to its comparatively lower efficacy rating, reports LA Times columnist Erika Smith.

from Greater LA

More from KCRW

Dr.

from KCRW Features

"Judging California’s climate change policies by greenhouse gas emissions is backwards.

from Zócalo's Connecting California

As California gears up to reopen in mid-June, the prospect of returning to the office is creating anxiety for the workforce that was forced to work from home due to the COVID-19…

from Greater LA

For years there has been a symbiotic relationship between these two giants but its time for increased transparency and some guiderails governing appropriate behaviors.

from Second Opinion

Documentarian Cullen Hoback maxed out his credit cards in his quest to unmask the person behind the pro-Trump QAnon conspiracy theory.

from The Business

Josh Barro talks with panelists Jamelle Bouie and Lanhee Chen about the housing aspect of Joe Biden’s infrastructure plan, how governors have fared in the pandemic and Georgia’s new…

from Left, Right & Center

This year kicked off with an alarming rise in shootings in Los Angeles, according to the LAPD’s public stats. Homicides are up, robberies are down, rapes are down, car thefts are up.

from Press Play with Madeleine Brand

Josh Barro speaks with panelists Christine Emba and Lanhee Chen about President Biden’s proposal for a major $2 trillion infrastructure package.

from Left, Right & Center

ArcLight and Pacific Theater locations all over LA and the country are closed for good now.

from Greater LA